News

Big Pharma booms despite Trump tariff headache
GSK is expected to report profit of £4.4 billion for the first half of this year. AstraZeneca is forecast to report a ...
Medical Dialogues11h
GSK Blenrep combos approved in EU for treatment of relapsed/refractory multiple myeloma
London: GSK plc has received approval for Blenrep in the European Union (EU) for the treatment of adults with relapsed or ...